Parathyroid hormone administration may modulate periodontal tissue levels of interleukin-6, matrix metalloproteinase-2 and matrix metalloproteinase-9 in experimental periodontitis

Journal of Periodontal Research

Volumn 44, Issue 6, 2009, Pages 744-750

  Marques, M R ^b   Dos Santos, M C L G ^b   Da Silva, A F ^b   Nociti Jr, F H ^b   Barros, S P ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Inflammatory cytokines; Matrix metalloproteinases; Parathyroid hormone; Periodontal disease

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOENZYME; MESSENGER RNA; MMP2 PROTEIN, RAT; PARATHYROID HORMONE; TARTRATE-RESISTANT ACID PHOSPHATASE;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; CELL COUNT; COMPARATIVE STUDY; CONNECTIVE TISSUE; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; GINGIVA; JAW; MALE; OSTEOCLAST; PATHOLOGY; PERIODONTITIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; WISTAR RAT;

ACID PHOSPHATASE; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; BIOLOGICAL MARKERS; CELL COUNT; CONNECTIVE TISSUE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GINGIVA; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1BETA; INTERLEUKIN-6; ISOENZYMES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOCLASTS; PARATHYROID HORMONE; PERIODONTITIS; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

EID: 70350520377     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2008.01186.x     Document Type: Article

References (34)

1. Baker PJ. The role of immune responses in bone loss during periodontal disease. Microbes Infect 2000 2 : 1181 1192.
2. Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000 289 : 1508 1514.
3. Feldmann M, Brennan FM, Foxwell BM, Maini RN. The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001 3 : 188 199.
4. Mäkelä M, Salo T, Uitto VJ, Larjava H. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 1994 73 : 1397 1406.
5. Teng YT, Sodek J, McCulloch CA. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Peridont Res 1992 27 : 544 552.
6. Ingman T, Tervahartiala T, Ding Y et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996 23 : 1127 1132.
7. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S et al. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003 74 : 188 195.
8. Barros SP, Silva MA, Somerman MJ, Nociti FH Jr. Parathyroid hormone protects against periodontitis-associated bone loss. J Dent Res 2003 82 : 791 795.
9. Marques MR, da Silva MA, Manzi FR, Cesar-Neto JB, Nociti FH Jr., Barros SP. Effect of intermittent PTH administration in the periodontitis-associated bone loss in ovariectomized rats. Arch Oral Biol 2005 50 : 421 429.
10. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001 344 : 1434 1441.
11. Hodsman AB, Bauer DC, Dempster D et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005 26 : 688 703.
12. Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007 40 : 1434 1446.
13. Hodsman AB, Hanley DA, Watson PH, Fraher LJ. Parathyroid hormone. In : Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego : Academic Press, 2002 : 1305 1324.
14. Manuele S, Sorbello L, Puglisi N et al. The teriparatide in the treatment of severe senile osteoporosis. Arch Gerontol Geriatr 2007 44 : 249 258.
15. Maugeri D, Russo E, Luca S et al. Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide. Arch Gerontol Geriatr 2008 (in press).
16. Fukata S, Hagino H, Okano T et al. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis. Arthritis Rheum 2004 50 : 4060 4069.
17. Schett G, Middleton S, Bolon B et al. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models. Arthritis Rheum 2005 52 : 1604 1611.
18. de Souza AP, Gerlach RF, Line SR. Inhibition of human gingival gelatinases (MMP-2 and MMP-9) by metal salts. Dent Mater 2000 16 : 103 108.
19. Souza AP, Gerlach RF, Line SR. Inhibition of human gelatinases by metals released from dental amalgam. Biomaterials 2001 22 : 2025 2030.
20. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982 34 : 285 290.
21. Yago T, Nanke Y, Kawamoto M et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther 2007 9 : R96.
22. Yu JJ, Ruddy MJ, Conti HR, Boonanantanasarn K, Gaffen SL. The IL-17 receptor plays a gender-dependent role in host protection against P. gingivalis-induced periodontal bone loss. Infect Immun 2008 76 : 4206 4213.
23. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in inflamed gingival by combined in situ hybridization and immunohistochemistry. Immunology 1992 76 : 42 47.
24. Liang JD, Hock JM, Sandusky GE, Santerre RF, Onyia JE. Immunohistochemical localization of selected early response gene expressed in trabecular bone of young rat given hPTH 1-34. Calcif Tissue Int 1999 65 : 369 373.
25. Onyia JE, Bidwell J, Herring J, Hulman J, Hock JM. In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression but not proliferation, in trabecular bone cells of young rats. Bone 1995 17 : 479 484.
26. Sanders JL, Stern PH. Protein kinase C involvement in interleukin-6 production by parathyroid hormone and tumor necrosis factor-alpha in UMR-106 osteoblastic cells. J Bone Miner Res 2000 15 : 885 893.
27. Buxton EC, Yao Wei, Lane NE. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metabol 2004 89 : 3332 3336.
28. Pattamapun K, Tiranathanagul S, Yongchaitrakul T, Kuwatanasuchat J, Pavasant P. Activation of MMP-2 by Porphyromonas gingivalis in human periodontal ligament cells. J Periodont Res 2003 38 : 115 121.
29. Creemers LB, Jansen ID, Docherty AJ, Reynolds JJ, Beertsen W, Everts V. Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol 1998 17 : 35 46.
30. Westerlund U, Ingman T, Lukinmaa PL et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996 75 : 1553 1563.
31. Kylmäniemi M, Oikarinen A, Oikarinen K, Salo T. Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. J Dent Res 1996 75 : 919 926.
32. McClelland P, Onyia JE, Miles RR. Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone. J Cell Biochem 1998 70 : 391 401.
33. Selvamurugan N, Pulumati MR, Tyson DR, Partridge NC. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J Biol Chem 2000 275 : 5037 5042.
34. Merciris D, Schiltz C, Legoupil N, Marty-Morieux C, de Vernejoul MC, Geoffroy V. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH. Bone 2007 40 : 75 83.